Substance Use Disorder (SUD)DYNA-NLPNCT07595614
NLP Analysis of Weekly Narratives for Dynamic Clinical Assessment in SUD
An observational study of Substance Use Disorder (SUD) and Addiction, run by Lauro Gutiérrez Castro at 1 site in Mexico.
Trial summary
This prospective observational study follows adults undergoing residential rehabilitation for severe substance use disorders at a specialized treatment center in Mexico. Participants provide weekly written narratives describing their emotions, challenges, coping strategies, and treatment experiences, and complete… Read more about this study
- Who is it for?
- Ages 18 years and older, men only
- Conditions the study is for
- Substance Use Disorder (SUD), Addiction, Anxiety
- What is being tested?
- Residential rehabilitation as usual
- How many people
- 35 participants
- Where
- 1 siteMexico
- Study dates
- 25 May 2025to Sep 2026
- How long will I take part?
- 20 Weeks
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- No healthy volunteers
- Adult, Older adult
Study population: Adult males (≥18 years) with severe substance use disorder, residing in a single residential rehabilitation center in Mexico. Participants are enrolled consecutively as they enter the program and meet eligibility criteria. The sample is non-probabilistic, reflecting the real-world clinical population of this specific center.
Who may be able to join
- Clinical diagnosis of severe substance use disorder (polydrug use, including cocaine, methamphetamines, alcohol, and/or cannabis), confirmed by the center's admission assessment.
- Male sex (all participants in the center's residential program are male).
- Age 18 years or older.
- Current resident of the participating residential rehabilitation center in Mexico.
- Completed at least four weeks of residential treatment at the time of study enrollment.
- Able to write coherent weekly narratives in Spanish (no severe cognitive impairment or active psychosis).
- Willing to provide written informed consent.
Who cannot join
- Presence of acute psychotic symptoms that interfere with the ability to write or understand the study procedures.
- Severe cognitive impairment (e.g., due to traumatic brain injury, intellectual disability) that prevents meaningful narrative production.
- Inability to comply with weekly narrative writing (e.g., illiteracy, severe visual impairment).
- Planned discharge from the residential program within less than 4 weeks from enrollment.
- Enrollment in another interventional clinical trial that could confound the interpretation of outcomes.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Ricardo Fernandez contact
Mexico1 site, 1 recruiting
- Recruiting
Under The Tree Potrerillos
Potrerillos, Jalisco, 45815
Lauro Gutiérrez Castro, +523314696107, saraqael_sefer@hotmail.com
About this study
Official title: Analysis of Weekly Narratives Using Natural Language Processing in Patients Undergoing Residential Rehabilitation: A Hybrid Approach for the Dynamic Assessment of Clinical Processes
This prospective observational study follows adults undergoing residential rehabilitation for severe substance use disorders at a specialized treatment center in Mexico. Participants provide weekly written narratives describing their emotions, challenges, coping strategies, and treatment experiences, and complete validated psychological questionnaires every two weeks, including the Generalized Anxiety Disorder-7 (GAD-7), Environmental Reward Observation Scale (EROS), Automatic Thoughts Questionnaire-8 (ATQ-8), and Behavioral Activation for Depression Scale (BADS).
The study applies natural language processing (NLP) and machine learning methods to analyze participants' narratives and identify emotional, cognitive, and behavioral patterns associated with clinical change over time. Narrative-derived features are combined with questionnaire scores to generate a dynamic clinical risk representation that may help detect early signs of psychological worsening or improvement during residential treatment.
Participants continue receiving standard residential care, and the study does not modify treatment decisions or clinical interventions. Up to 35 participants with sufficient longitudinal follow-up data will be included in the primary analysis. Data collection is expected to continue through September 2026.
Read the detailed description
Patients undergoing treatment for substance use disorders frequently describe changes in mood, motivation, hopelessness, cognitive rigidity, emotional distress, and coping strategies through spontaneous written language. These narratives may contain clinically meaningful indicators associated with psychological deterioration, treatment progress, or relapse vulnerability. However, systematic manual analysis of longitudinal written narratives is difficult to implement in routine clinical practice because of the volume and complexity of the data.
Recent developments in natural language processing (NLP), representation learning, and deep learning provide methods for extracting quantitative linguistic and semantic information from written text. Integrating these features with repeated psychometric assessments may support the development of longitudinal models capable of characterizing changes in mental health status over time in patients receiving residential addiction treatment.
Objectives
The objectives of this study are:
To extract semantic, emotional, and linguistic features from weekly patient narratives using NLP methods, including sentence embeddings, sentiment and emotion classification, and semantic similarity analyses based on Acceptance and Commitment Therapy (ACT) constructs.
To integrate narrative-derived variables with repeated psychometric measures (Generalized Anxiety Disorder-7 (GAD-7), Environmental Reward Observation Scale (EROS), Automatic Thoughts Questionnaire-8 (ATQ-8), and Behavioral Activation for Depression Scale (BADS)) using a multimodal deep learning autoencoder capable of generating a low-dimensional representation of longitudinal clinical status.
To evaluate whether latent representations generated by the autoencoder are associated with periods of clinical worsening or clinical improvement across time using leave-one-patient-out cross-validation procedures.
To develop a dynamic longitudinal risk representation capable of estimating future changes in automatic negative thoughts, measured through subsequent ATQ-8 scores.
Study Design
This study is a prospective observational cohort conducted at a single residential rehabilitation center in Mexico.
Eligible participants are adults aged 18 years or older with a diagnosis of severe substance use disorder who are admitted for residential treatment. Individuals with active psychotic symptoms or cognitive impairment that substantially interferes with the ability to complete written narratives are excluded.
Participants complete:
Weekly digital written narratives using open-ended prompts focused on emotions, challenges, coping responses, interpersonal experiences, and perceived treatment progress.
Biweekly administration of the following validated self-report instruments:
GAD-7
EROS
ATQ-8
BADS
All information is collected through digital forms integrated into routine clinical monitoring procedures at the treatment center.
Participants may contribute data for up to 20 weeks, depending on duration of residential stay. The study began on 25 May 2025, and primary completion is anticipated in September 2026.
Up to 35 participants with sufficient longitudinal observations will be included in the primary analytic cohort.
NLP and Machine Learning Pipeline
Text preprocessing
Narratives are written in Spanish and undergo preprocessing procedures that include:
minimum length filtering, normalization, consolidation of narrative fields into a single weekly text sample, tokenization and linguistic annotation.
Feature extraction
Narrative features include:
Sentiment classification (positive, neutral, negative) Emotion probabilities for joy, sadness, anger, fear, surprise, and disgust using the pysentimiento library
Linguistic variables including:
type-token ratio, mean sentence length, proportion of first-person pronouns, proportion of past-tense verbs, obtained through udpipe
Semantic similarity measures between patient narratives and ACT-related prototype domains including:
experiential avoidance, cognitive fusion, rule-governed behavior, helplessness, achievement orientation, hopefulness
Semantic similarity is computed through cosine similarity between sentence-transformer embeddings and predefined prototype centroids.
Dimensionality reduction procedures using principal component analysis (PCA) are applied to selected linguistic and semantic variables to derive a principal component representing orientation toward internal emotional experience versus external contextual events.
Autoencoder Architecture
The multimodal model receives concatenated longitudinal feature vectors after robust scaling.
The architecture includes:
a bidirectional long short-term memory (BiLSTM) encoder, multi-head attention mechanisms, variational regularization using a β-variational autoencoder (β-VAE) framework, a decoder trained to reconstruct the original temporal feature sequence, and an auxiliary classification component predicting next-period clinical worsening.
The training objective combines:
mean squared reconstruction error, focal loss for classification, Kullback-Leibler divergence, and optional temporal smoothness regularization.
Model performance is evaluated using leave-one-patient-out cross-validation procedures. A final model may subsequently be trained using the complete dataset.
Primary Analyses
Primary analyses include:
evaluation of discriminative performance for prediction of subsequent clinical worsening using: area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), F1 score, Matthews correlation coefficient (MCC) examination of associations between latent trajectory representations and longitudinal psychometric changes, development of a Composite Clinical Risk Index (CCRI) derived from latent representations, and comparison of CCRI trajectories with weeks classified as clinical worsening according to predefined multimodal criteria.
Ethics and Dissemination
The study has received approval from the institutional review board of Under The Tree Miller A.C.
All participants provide written informed consent prior to participation.
Participation does not alter or replace standard residential treatment. All clinical decisions remain under the responsibility of treating professionals independent of study procedures.
Study findings will be submitted for publication in peer-reviewed scientific journals regardless of outcome. De-identified datasets and analysis code may be made available upon reasonable request and in accordance with institutional and ethical requirements.
Recruitment Status
Recruitment is ongoing. Final data collection for the primary outcome is anticipated in September 2026.
- Conditions
- Substance Use Disorder (SUD), Addiction, Anxiety, Emotional Dysregulation, Rumination - Thoughts
- Being tested
- Residential rehabilitation as usual
- Keywords
- Natural Language Processing, Machine Learning, Behavioral Activation, Automatic Thoughts, Residential Rehabilitation
- Medical subject headings
- Substance-Related Disorders, Behavior, Addictive, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Residential rehabilitation as usualOther
Participants follow the standard residential rehabilitation program provided by the center. This is a naturalistic exposure; the study does not impose any additional intervention. The "intervention" of interest is the routine therapeutic environment and its associated psychological processes (e.g., changes in avoidance, cognitive fusion, hope, and behavioral activation). These processes are measured through weekly written narratives and biweekly validated clinical scales (GAD-7, EROS, ATQ-8, BADS).
| Study group | Role | What they receive |
|---|---|---|
| Residential rehabilitation cohort | Adult men (≥18 years) with severe substance use disorder, admitted to a residential rehabilitation center in Mexico. All participants receive the center's standard, multimodal treatment program, which includes group therapy, individual counseling, occupational activities, 12-step facilitation, and relapse prevention education. The study does not assign, modify, or withhold any component of this program. Participants are followed prospectively for the duration of their stay (10-20 weeks). Receives: Other: Residential rehabilitation as usual |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in negative automatic thoughts measured by the Automatic Thoughts Questionnaire 8-item version
The Automatic Thoughts Questionnaire 8-item version is administered every two weeks. Total scores range from 8 to 40, with higher scores indicating more frequent negative automatic thoughts. The primary outcome is the change from baseline in total score over the course of residential treatment.
Measured: Every 2 weeks from baseline until discharge from residential treatment (up to 20 weeks)
Secondary outcomes (5)
Change in generalized anxiety symptoms measured by the Generalized Anxiety Disorder 7 item scale
The Generalized Anxiety Disorder 7-item scale is administered every two weeks. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity.
Measured: Every 2 weeks from baseline until discharge (up to 20 weeks)
Change in environmental reward measured by the Environmental Reward Observation Scale
The Environmental Reward Observation Scale iis administered every two weeks. Total scores range from 10 to 40, with higher scores indicating greater exposure to positive environmental reinforcement.
Measured: Every 2 weeks from baseline until discharge (up to 20 weeks)
Change in behavioral activation and avoidance measured by the Behavioral Activation for Depression Scale
The Behavioral Activation for Depression Scale is administered every two weeks. Higher scores on the Activation subscale indicate greater engagement in goal-directed activity; higher scores on the Avoidance/Rumination subscale indicate greater behavioral avoidance and rumination.
Measured: Every 2 weeks from baseline until discharge (up to 20 weeks)
Weekly self-reported emotional intensity
Participants report the intensity of their predominant weekly emotion on a 0 to 10 numeric rating scale, where higher scores indicate greater emotional intensity.
Measured: Weekly from baseline until discharge (up to 20 weeks)
Weekly self-reported craving intensity
Participants rate average craving for substance use during the prior week on a 0 to 10 numeric rating scale, where higher scores indicate greater craving intensity.
Measured: Weekly from baseline until discharge (up to 20 weeks)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2026
- Study start25 May 2025
- Primary completionSep 2026 (estimated)
- Study completionSep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Substance Use Disorder (SUD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 35 participants (estimated)
- Target duration
- 20 Weeks
Sponsor and investigators
- Lead sponsor
- Lauro Gutiérrez Castro
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Lauro Gutiérrez Castro, Under The Tree Therapeutic Community
- Investigators
- Lauro Gutiérrez Castro, Principal investigator, Under The Tree
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07595614
- Sponsor's protocol ID
- SISAP-TUS-HYB/WN-01
- Acronym
- DYNA-NLP
- Status last verified
- May 2026
- First submitted
- 9 May 2026
- Last updated
- 19 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual participant data (IPD) from the weekly narratives and biweekly clinical scales, after removal of all direct identifiers (name, date of birth, exact dates converted to study day/week numbers). Only aggregated or pseudonymized data will be shared.
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Analysis of Weekly Narratives Using Natural Language Processing in Patients Undergoing Residential Rehabilitation: A Hybrid Approach for the Dynamic Assessment of Clinical Processes
- ClinicalTrials.gov ID
- NCT07595614
- Acronym / sponsor ID
- DYNA-NLP / SISAP-TUS-HYB/WN-01
- Conditions
- Substance Use Disorder (SUD), Addiction, Anxiety, Emotional Dysregulation, Rumination - Thoughts
- Keywords
- Natural Language Processing, Machine Learning, Behavioral Activation, Automatic Thoughts, Residential Rehabilitation
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 35 participants (estimated)
- Lead sponsor
- Lauro Gutiérrez CastroUniversity, hospital or other
- Study start
- 25 May 2025 (actual)
- Primary completion
- Sep 2026 (estimated)
- Study completion
- Sep 2026 (estimated)
- First posted
- 19 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This prospective observational study follows adults undergoing residential rehabilitation for severe substance use disorders at a specialized treatment center in Mexico. Participants provide weekly written narratives describing their emotions, challenges, coping strategies, and treatment experiences, and complete validated psychological questionnaires every two weeks, including the Generalized Anxiety Disorder-7 (GAD-7), Environmental Reward Observation Scale (EROS), Automatic Thoughts Questionnaire-8 (ATQ-8), and Behavioral Activation for Depression Scale (BADS).
The study applies natural language processing (NLP) and machine learning methods to analyze participants' narratives and identify emotional, cognitive, and behavioral patterns associated with clinical change over time. Narrative-derived features are combined with questionnaire scores to generate a dynamic clinical risk representation that may help detect early signs of psychological worsening or improvement during residential treatment.
Participants continue receiving standard residential care, and the study does not modify treatment decisions or clinical interventions. Up to 35 participants with sufficient longitudinal follow-up data will be included in the primary analysis. Data collection is expected to continue through September 2026.
Detailed description
Patients undergoing treatment for substance use disorders frequently describe changes in mood, motivation, hopelessness, cognitive rigidity, emotional distress, and coping strategies through spontaneous written language. These narratives may contain clinically meaningful indicators associated with psychological deterioration, treatment progress, or relapse vulnerability. However, systematic manual analysis of longitudinal written narratives is difficult to implement in routine clinical practice because of the volume and complexity of the data.
Recent developments in natural language processing (NLP), representation learning, and deep learning provide methods for extracting quantitative linguistic and semantic information from written text. Integrating these features with repeated psychometric assessments may support the development of longitudinal models capable of characterizing changes in mental health status over time in patients receiving residential addiction treatment.
Objectives
The objectives of this study are:
To extract semantic, emotional, and linguistic features from weekly patient narratives using NLP methods, including sentence embeddings, sentiment and emotion classification, and semantic similarity analyses based on Acceptance and Commitment Therapy (ACT) constructs.
To integrate narrative-derived variables with repeated psychometric measures (Generalized Anxiety Disorder-7 (GAD-7), Environmental Reward Observation Scale (EROS), Automatic Thoughts Questionnaire-8 (ATQ-8), and Behavioral Activation for Depression Scale (BADS)) using a multimodal deep learning autoencoder capable of generating a low-dimensional representation of longitudinal clinical status.
To evaluate whether latent representations generated by the autoencoder are associated with periods of clinical worsening or clinical improvement across time using leave-one-patient-out cross-validation procedures.
To develop a dynamic longitudinal risk representation capable of estimating future changes in automatic negative thoughts, measured through subsequent ATQ-8 scores.
Study Design
This study is a prospective observational cohort conducted at a single residential rehabilitation center in Mexico.
Eligible participants are adults aged 18 years or older with a diagnosis of severe substance use disorder who are admitted for residential treatment. Individuals with active psychotic symptoms or cognitive impairment that substantially interferes with the ability to complete written narratives are excluded.
Participants complete:
Weekly digital written narratives using open-ended prompts focused on emotions, challenges, coping responses, interpersonal experiences, and perceived treatment progress.
Biweekly administration of the following validated self-report instruments:
GAD-7
EROS
ATQ-8
BADS
All information is collected through digital forms integrated into routine clinical monitoring procedures at the treatment center.
Participants may contribute data for up to 20 weeks, depending on duration of residential stay. The study began on 25 May 2025, and primary completion is anticipated in September 2026.
Up to 35 participants with sufficient longitudinal observations will be included in the primary analytic cohort.
NLP and Machine Learning Pipeline
Text preprocessing
Narratives are written in Spanish and undergo preprocessing procedures that include:
minimum length filtering, normalization, consolidation of narrative fields into a single weekly text sample, tokenization and linguistic annotation.
Feature extraction
Narrative features include:
Sentiment classification (positive, neutral, negative) Emotion probabilities for joy, sadness, anger, fear, surprise, and disgust using the pysentimiento library
Linguistic variables including:
type-token ratio, mean sentence length, proportion of first-person pronouns, proportion of past-tense verbs, obtained through udpipe
Semantic similarity measures between patient narratives and ACT-related prototype domains including:
experiential avoidance, cognitive fusion, rule-governed behavior, helplessness, achievement orientation, hopefulness
Semantic similarity is computed through cosine similarity between sentence-transformer embeddings and predefined prototype centroids.
Dimensionality reduction procedures using principal component analysis (PCA) are applied to selected linguistic and semantic variables to derive a principal component representing orientation toward internal emotional experience versus external contextual events.
Autoencoder Architecture
The multimodal model receives concatenated longitudinal feature vectors after robust scaling.
The architecture includes:
a bidirectional long short-term memory (BiLSTM) encoder, multi-head attention mechanisms, variational regularization using a β-variational autoencoder (β-VAE) framework, a decoder trained to reconstruct the original temporal feature sequence, and an auxiliary classification component predicting next-period clinical worsening.
The training objective combines:
mean squared reconstruction error, focal loss for classification, Kullback-Leibler divergence, and optional temporal smoothness regularization.
Model performance is evaluated using leave-one-patient-out cross-validation procedures. A final model may subsequently be trained using the complete dataset.
Primary Analyses
Primary analyses include:
evaluation of discriminative performance for prediction of subsequent clinical worsening using: area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), F1 score, Matthews correlation coefficient (MCC) examination of associations between latent trajectory representations and longitudinal psychometric changes, development of a Composite Clinical Risk Index (CCRI) derived from latent representations, and comparison of CCRI trajectories with weeks classified as clinical worsening according to predefined multimodal criteria.
Ethics and Dissemination
The study has received approval from the institutional review board of Under The Tree Miller A.C.
All participants provide written informed consent prior to participation.
Participation does not alter or replace standard residential treatment. All clinical decisions remain under the responsibility of treating professionals independent of study procedures.
Study findings will be submitted for publication in peer-reviewed scientific journals regardless of outcome. De-identified datasets and analysis code may be made available upon reasonable request and in accordance with institutional and ethical requirements.
Recruitment Status
Recruitment is ongoing. Final data collection for the primary outcome is anticipated in September 2026.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 20 Weeks
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Residential rehabilitation cohort | – | Other: Residential rehabilitation as usualAdult men (≥18 years) with severe substance use disorder, admitted to a residential rehabilitation center in Mexico. All participants receive the center's standard, multimodal treatment program, which includes group therapy, individual counseling, occupational activities, 12-step facilitation, and relapse prevention education. The study does not assign, modify, or withhold any component of this program. Participants are followed prospectively for the duration of their stay (10-20 weeks). |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult males (≥18 years) with severe substance use disorder, residing in a single residential rehabilitation center in Mexico. Participants are enrolled consecutively as they enter the program and meet eligibility criteria. The sample is non-probabilistic, reflecting the real-world clinical population of this specific center.
Key inclusion criteria (7 listed)
- Clinical diagnosis of severe substance use disorder (polydrug use, including cocaine, methamphetamines, alcohol, and/or cannabis), confirmed by the center's admission assessment.
- Male sex (all participants in the center's residential program are male).
- Age 18 years or older.
- Current resident of the participating residential rehabilitation center in Mexico.
- Completed at least four weeks of residential treatment at the time of study enrollment.
Key exclusion criteria (5 listed)
- Presence of acute psychotic symptoms that interfere with the ability to write or understand the study procedures.
- Severe cognitive impairment (e.g., due to traumatic brain injury, intellectual disability) that prevents meaningful narrative production.
- Inability to comply with weekly narrative writing (e.g., illiteracy, severe visual impairment).
- Planned discharge from the residential program within less than 4 weeks from enrollment.
- Enrollment in another interventional clinical trial that could confound the interpretation of outcomes.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Residential rehabilitation as usualParticipants follow the standard residential rehabilitation program provided by the center. This is a naturalistic exposure; the study does not impose any additional intervention. The "intervention" of interest is the routine therapeutic environment and its associated psychological processes (e.g., changes in avoidance, cognitive fusion, hope, and behavioral activation). These processes are measured through weekly written narratives and biweekly validated clinical scales (GAD-7, EROS, ATQ-8, BADS). | Other | Residential rehabilitation cohort |
Primary outcome
Change in negative automatic thoughts measured by the Automatic Thoughts Questionnaire 8-item version
Time frame: Every 2 weeks from baseline until discharge from residential treatment (up to 20 weeks)
The Automatic Thoughts Questionnaire 8-item version is administered every two weeks. Total scores range from 8 to 40, with higher scores indicating more frequent negative automatic thoughts. The primary outcome is the change from baseline in total score over the course of residential treatment.
5 secondary outcomes
Change in generalized anxiety symptoms measured by the Generalized Anxiety Disorder 7 item scale
Time frame: Every 2 weeks from baseline until discharge (up to 20 weeks)
Change in environmental reward measured by the Environmental Reward Observation Scale
Time frame: Every 2 weeks from baseline until discharge (up to 20 weeks)
Change in behavioral activation and avoidance measured by the Behavioral Activation for Depression Scale
Time frame: Every 2 weeks from baseline until discharge (up to 20 weeks)
Weekly self-reported emotional intensity
Time frame: Weekly from baseline until discharge (up to 20 weeks)
Weekly self-reported craving intensity
Time frame: Weekly from baseline until discharge (up to 20 weeks)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2026.
- Individual participant dataSharing planned: Yes. De-identified individual participant data (IPD) from the weekly narratives and biweekly clinical scales, after removal of all direct identifiers (name, date of birth, exact dates converted to study day/week numbers). Only aggregated or pseudonymized data will be shared.
Related trials for Substance Use Disorder (SUD)
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Active, not recruiting
EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy
Substance Use Disorders, Opioid Use Disorder, Severe
Recruiting
The Trans-Led Care Study
Substance Abuse, Substance Addiction
Not yet recruitingObservational study
Disease Intervention Specialist (DIS) for SUD
Substance Use Disorder (SUD), Opioid Use Disorder
RecruitingEarly Phase 1
Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.
Substance Use Disorder (SUD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ricardo Fernandez contact
Lauro Gutiérrez Castro principal investigator
Under The Tree
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Substance Use Disorder (SUD) and Addiction, run by Lauro Gutiérrez Castro at 1 site in Mexico.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Lauro Gutiérrez Castro (+523314696107, saraqael_sefer@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in negative automatic thoughts measured by the Automatic Thoughts Questionnaire 8-item version (time frame: Every 2 weeks from baseline until discharge from residential treatment (up to 20 weeks)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.